Last reviewed · How we verify
NCT02993965
State Immunization Information Systems to Improve HPV Vaccination Rates
NA trial testing Vaccine Reminder/Recall in Vaccine in 77,716 participants. Completed in 31 July 2020.
15 March 2019
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 77,716 |
| Start date | 21 February 2017 |
| Primary completion | 15 March 2019 |
| Estimated completion | 31 July 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Vaccine Reminder/Recall
Conditions studied
- Vaccine — all drugs for Vaccine →
- Human Papiloma Virus Vaccine — all drugs for Human Papiloma Virus Vaccine →
- HPV Vaccine — all drugs for HPV Vaccine →
- Immunization — all drugs for Immunization →
Sponsor
University of Colorado, Denver
Who can join
Adults 11 to 17, any sex, with Vaccine or Human Papiloma Virus Vaccine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Centralized Reminder/Recall for Human Papillomavirus Vaccination: Findings From Two States-A Randomized Clinical Trial.
Gurfinkel D, Kempe A, Albertin C, Breck A, et al · · 2021 · cited 15× · PMID 33846054 · DOI 10.1016/j.jadohealth.2021.02.023
Verify or expand the search:
- PubMed search for NCT02993965
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaccine
Currently open trials in the same condition.
- NCT07016152 — An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae · Phase 1 · recruiting
- NCT06682117 — A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor · NA · recruiting
- NCT06128928 — Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities · NA · recruiting
- NCT04083950 — Induction of Gut Permeability by an Oral Vaccine · EARLY_PHASE1 · active not recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02993965 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 20 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02993965.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing